Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Total Marrow Irradiation for Refractory Acute Leukemia

    ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  2. Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    ...

    Clinical Trial last updated 04/28/2016 - 1:17pm.

  3. Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed/Refractory Acute Leukemia or High-Risk MDS

    ...

    Clinical Trial last updated 04/28/2016 - 9:55am.

  4. Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    ...

    Clinical Trial last updated 04/28/2016 - 9:51am.

  5. Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron

    ... ring sideroblasts (RS). RS is a cardinal feature of refractory anemia with RS (RARS) and RARS with marked ...

    Research Article last updated 06/02/2014 - 10:42am.

  6. Pediatric myelodysplastic syndromes: they do exist!

    ... hypocellular bone marrow and monosomy 7 . Refractory cytopenia is more typical than refractory anemia , as seen in the elderly. Its recognition and ...

    Research Article last updated 01/08/2014 - 9:02am.

  7. Tea consumption reduces the risk of de novo myelodysplastic syndromes

    ... The inverse association existed in both genders, in the refractory anemia with excessive blasts subtype, in ... System lower and higher risk groups, but not in the refractory cytopenia with multilineage dysplasia subtype. The study ...

    Research Article last updated 01/20/2015 - 12:56pm.

  8. Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    ...

    Clinical Trial last updated 04/21/2016 - 9:26am.

  9. The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems.

    ... with myelodysplastic syndromes (MDS), namely refractory anemia with excess blasts (RAEB) and chronic ...

    Research Article last updated 05/14/2013 - 2:59pm.

  10. 5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials

    ... 5+2 +2): seven patients were classified as having refractory cytopenia with multilineage dysplasia (RCMD), nine patients with refractory anemia with excess of blasts (RAEB) type 1, 18 ...

    Research Article last updated 06/15/2012 - 2:13pm.